Abstract
Objective Favourable trends in cardiovascular disease (CVD) risk factors at the population level potentially mask differences within high- and low-risk groups. Data from annual, repeated cross-sectional surveys (Health Survey for England 2003-18) was used to examine trends in the prevalence of key CVD risk factors by body mass index (BMI) category among adults aged 16 years or older (n = 115,860).
Methods Six risk factors were investigated: (i) current cigarette smoking; (ii) physical inactivity (< 30 minutes of moderate-to-vigorous physical activity per week); (iii) drinking above recommended daily alcohol limits; (iv) hypertension (measured blood pressure ≥140/90mmHg or use of medicine prescribed for high blood pressure); (v) total diabetes (reported diagnosed or elevated glycated haemoglobin); and (vi) raised total cholesterol (≥5mmol/L). Age-standardised risk factor prevalence was computed in each four-year time period (2003-06; 2007-10; 2011-14; 2015-18) in all adults and by BMI category (normal-weight; overweight; obesity). Change in risk factor prevalence on the absolute scale was computed as the difference between the first and last time-periods, expressed in percentage points (PP).
Results Risk factor change varied by BMI category in a number of cases. Current smoking prevalence fell more sharply for normal-weight men (−8.1 PP; 95% CI: -10.3, -5.8) versus men with obesity (−3.8 PP; 95% CI: -6.2, -1.4). Hypertension remained at a stable level among normal-weight men but decreased among men with obesity (−4.1 PP; 95% CI: -7.1, -1.0). Total diabetes remained at a stable level among normal-weight adults, but increased among adults with obesity (men: 3.5 PP; 95% CI: 1.2, 5.7; women: 3.6 PP; 95% CI: 1.8, 5.4). Raised total cholesterol decreased in all BMI groups, but fell more sharply among women with obesity (−21 PP; 95% CI: -25, -17) versus their normal-weight counterparts (−16 PP; 95% CI: -18, -14).
Conclusions Relative to adults with normal weight, greater reductions in hypertension and raised total cholesterol among adults with overweight and obesity reflect at least in part improvements in screening, treatment and control among those at highest cardiovascular risk. Higher levels of risk factor prevalence among adults with overweight and obesity, in parallel with rising diabetes, highlight the importance of national prevention efforts to combat the public health impact of excess adiposity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Health Survey for England was funded by NHS Digital. NHS Digital is the trading name of the Health and Social Care Information Centre. The authors are funded to conduct the annual HSE but this specific study was not funded. NHS Digital had no role in the analysis, interpretation of data, decision to publish or preparation of the manuscript for this specific study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The procedures used in the HSE to obtained informed consent from survey participants are very closely scrutinised by a NHS ethics committee each year. Approval was obtained from the following Research Ethics Committees (REC): HSE 2003, 2005, 2006 and 2007: London Multi-Centre REC; HSE 2008: Oxford A REC: 07/H0604/102; HSE 2009: Oxford B REC: 08/H0605/103; HSE 2010: Oxford B REC: 09/H0605/73; HSE 2011 and 2012: Oxford A REC: 10/H0604/56; HSE 2013 and 2014: Oxford A REC: 12/sc/0317; HSE 2015: West London NRES Committee: 14/LO/0862; HSE 2016, 2017 and 2018: Nottingham REC: 15/EE/0299. This study is a secondary analysis of previously collected data and so additional ethical approval was not required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- BMI
- body mass index
- BP
- blood pressure
- CVD
- cardiovascular disease
- HSE
- Health Survey for England
- MVPA
- moderate-to-vigorous physical activity
- NCDs
- noncommunicable diseases
- NHANES
- National Health and Nutrition Examination Survey
- PA
- physical activity
- PP
- percentage change
- UKDS
- UK Data Service
- WHO
- World Health Organization
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos